FRAZIER LIFE SCIENCES XI, L.P. enters ATTOVIA THERAPEUTICS, INC. with 75.35K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/4/2026ACC: 0001231919-26-000827
10% Owner
Since Aug 2026
75.35K
Baseline shares
100% direct
75.35K
Direct ownership
1 position
5.49M
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned75.35K
Total
75.35K direct75.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 75.35K | Direct |
| Total | 75.35K | 75.35K direct |
Derivative Holdings4
Series B Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
1.19M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Series A-1 Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
1.75M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Series C Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
961.32K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Series A-2 Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
1.59M
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
5.49M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock | 0 | — | — | 1.19M | N/A |
| Series A-1 Preferred Stock Direct | Common Stock | 0 | — | — | 1.75M | N/A |
| Series C Preferred Stock Direct | Common Stock | 0 | — | — | 961.32K | N/A |
| Series A-2 Preferred Stock Direct | Common Stock | 0 | — | — | 1.59M | N/A |
| Total | 5.49M | 0.00 | ||||